: Praised for its robust drug pipeline and use of AI in cancer treatments.
: Recommended as a "magical" play on skyrocketing electricity demand for data centers. cramer buy
Several academic papers have analyzed the effectiveness of Cramer’s picks on CNBC's Mad Money : : Praised for its robust drug pipeline and
As of late April 2026, Cramer has shifted his focus toward healthcare and "legacy" companies effectively deploying AI. cramer buy